|
Recipient gender (M/F)
|
2/3
|
6/1
|
0.10
|
|
Recipient age at transplantation (mean ± SD)
|
33.7 ± 9.7
|
36.6 ± 8.6
|
0.75
|
|
Donor age at transplantation (mean ± SD)
|
57.7 ± 15.5
|
53.1 ± 17.1
|
1.00
|
|
Duration of pre-transplant dialysis (months)
|
41.3 ± 42.1
|
9.6 ± 3.6
|
0.10
|
|
Living/deceased
|
5/0
|
6/1
|
1.00
|
|
ABO compatible/incompatible
|
3/2
|
7/0
|
0.15
|
|
Immunosuppressant use (CsA/FK)
|
3/2
|
6/1
|
0.52
|
|
SCr at recurrence (mg/dl)
|
1.15 ± 0.28
|
1.29 ± 0.17
|
0.33
|
|
eGFR at recurrence (ml/min)
|
47.7 ± 14.6
|
39.1 ± 5.8
|
0.33
|
|
Urinary findings at recurrence
|
|
Hematuria
|
3/5 (60%)
|
4/7 (57%)
|
1.00
|
|
Proteinuria (g/g·Cr)
|
0.33 ± 0.52
|
0.07 ± 0.19
|
0.39
|
|
Use of RASI
|
5/5 (100%)
|
6/7 (85.7%)
|
1.00
|
|
Period between transplant and IgAN recurrence (months)
|
37.4 ± 25.7
|
31.8 ± 19.3
|
0.94
|
|
Median time between IgAN recurrence and tonsillectomy (months)
|
3.1(1.4 − 28.9)
|
–
|
–
|
|
Time between IgAN recurrence and the next protocol biopsy (months)
|
57.4 ± 10.1
|
61.4 ± 8.5
|
0.76
|
|
Follow-up period (months)
|
146.8 ± 30.1
|
193.6 ± 105.1
|
0.75
|
